FdaApplication

NDA 021335

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date2001-05-10

Products (2)

ProductActive ingredientStrengthDosage form
GLEEVECIMATINIB MESYLATEEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL
GLEEVECIMATINIB MESYLATEEQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL

2 products